American Century Companies’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $854K | Buy |
251,273
+19,098
| +8% | +$64.9K | ﹤0.01% | 2349 |
|
|
2025
Q1 | $931K | Buy |
232,175
+27,430
| +13% | +$110K | ﹤0.01% | 2275 |
|
|
2024
Q4 | $1.33M | Buy |
204,745
+19,802
| +11% | +$129K | ﹤0.01% | 2160 |
|
|
2024
Q3 | $1.02M | Buy |
184,943
+30,004
| +19% | +$166K | ﹤0.01% | 2224 |
|
|
2024
Q2 | $865K | Buy |
154,939
+28,449
| +22% | +$159K | ﹤0.01% | 2226 |
|
|
2024
Q1 | $849K | Buy |
126,490
+78,389
| +163% | +$526K | ﹤0.01% | 2218 |
|
|
2023
Q4 | $439K | Buy |
+48,101
| New | +$439K | ﹤0.01% | 2415 |
|